中文 | English
Return
Total: 6 , 1/1
Show Home Prev Next End page: GO
Author:(Kaixin WEI)

1.Chidamide plus prednisone, cyclophosphamide, and thalidomide for relapsed or refractory peripheral T-cell lymphoma: A multicenter phase II trial

Jinhua LIANG ; Li WANG ; Xiaodong WANG ; Guohui CUI ; Jianfeng ZHOU ; Tongyao XING ; Kaixin DU ; Jingyan XU ; Luqun WANG ; Rong LIANG ; Biyun CHEN ; Jian CHENG ; Haorui SHEN ; Jianyong LI ; Wei XU

Chinese Medical Journal 2024;137(13):1576-1582

2.Trend analysis of differentially expressed genes in retinoic acid-induced neural tube defects in mouse model

Rui CAO ; Kaixin WEI ; Xiaona ZHANG ; Yurong LIU ; Li ZHANG

Journal of Shanghai Jiaotong University(Medical Science) 2024;44(7):859-870

3.Metabonomics Combined with Prescription Compatibility Theory to Explore the Lipid-lowering Effect of Qige Decoction Compatibility

Kaixin GUO ; Hui TANG ; Yanfang LI ; Xiaoqing YU ; Haoyang WEI ; Keer HUANG ; Wei CHEN ; Xuehong KE

Traditional Chinese Drug Research & Clinical Pharmacology 2024;35(7):971-984

4.Changes and role of CD74 and CXCL9 positive macrophage subsets in rejection of rat liver transplantation

Sidong WEI ; Kaige CHEN ; Jixiang ZHANG ; Juanjuan XUAN ; Yaoquan WANG ; Shun MIAO ; Kaixin ZHAO ; Weiwei WANG ; Guoyong CHEN

The Journal of Practical Medicine 2023;39(23):3027-3033

5.Progress of chimeric antigen receptor T cells in treatment of B-cell lymphoma

Kaixin DU ; Wei XU

Journal of Leukemia & Lymphoma 2021;30(2):74-77

6. Investigate thenovel coronaviruses in external environmentof COVID-19

Zerun XUE ; Yang LUAN ; Hailong CHEN ; Quanli DU ; Yuewen HAN ; Yalan ZHANG ; Tongtong YU ; Xiaoguang WEI ; Hao LI ; Yujie YANG ; Yangni DENG ; Kaixin LI ; Ruihua TIAN ; Yongfeng WU ; Jie WEI ; Xian MA ; Chaofeng MA ; Rui WU ; Mingjun HU

Chinese Journal of Experimental and Clinical Virology 2020;34(0):E011-E011

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 6 , 1/1 Show Home Prev Next End page: GO